ANNOVIS BIO INC (ANVS): Institutional Ownership
Hedge funds and institutional managers reporting a position in ANVS · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$3.3M
Across holders
Last Price
$1.72
2026-06-26
Sector
Health Care
GICS
Holder activity2 new2 added1 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 628K | $1.4M | 42.7% | 0.0% | Added | +$169K | Q1 2026 |
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 348K | $775K | 23.7% | 0.0% | New | — | Q1 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. CIK 0001165408 | Hedge Fund | 100K | $576K | 17.6% | 0.0% | New | — | Q2 2024 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 189K | $420K | 12.8% | 0.0% | Reduced | $-903K | Q1 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 47K | $104K | 3.2% | 0.0% | Added | +$7K | Q1 2026 |
Added
Hedge Fund
$1.4M· 42.7% of total· 0.0% port· 628K sh· +$169K QoQ· Q1 2026
New
Hedge Fund
$775K· 23.7% of total· 0.0% port· 348K sh· — QoQ· Q1 2026
New
Hedge Fund
$576K· 17.6% of total· 0.0% port· 100K sh· — QoQ· Q2 2024
Reduced
Hedge Fund
$420K· 12.8% of total· 0.0% port· 189K sh· $-903K QoQ· Q1 2026
Added
Hedge Fund
$104K· 3.2% of total· 0.0% port· 47K sh· +$7K QoQ· Q1 2026